Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.87 USD | -3.25% | -5.61% | -43.71% |
06/05 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
16/04 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.71% | 36.9M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- SAB Biotherapeutics Executive Chairman Samuel Reich Adds CEO Role